pharma-company /Medicinal products /Active ingredients

Rx · PZN 11564473

DARZALEX 20 mg/ml 400mg-20ml concentrate for preparation of a solution for infusion

German trade nameDARZALEX 20 mg-ml 400mg-20ml Konzentrat zur Herstellung einer Infusionslösung

Active ingredientDaratumumabPharmaceutical formConcentrate for solution for infusion

Available with fluctuations

6.1

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €1,385

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for DARZALEX 20 mg/ml 400mg-20ml concentrate for preparation of a solution for infusion.

Review purchasing terms

DARZALEX 20 mg/ml 400mg-20ml concentrate for preparation of a solution for infusion contains the active ingredient Daratumumab and comes as Concentrate for solution for infusion. One pack size is recorded (PZN 11564473). The pharma availability index for German wholesale stands at 6.1 out of 10 over the past 30 days – the pack was therefore available with fluctuations.


Availability of DARZALEX 20 mg/ml 400mg-20ml concentrate for preparation of a solution for infusion fluctuates noticeably. We are happy to advise you on securing your supply through additional sources.

Secure your supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.